Managing the Cost of Non-Compliance.

The article reports that creating a quality culture can prevent the costs and challenges related to receiving a consent decree. The U.S. Food and Drug Administration (FDA) gives individuals and companies an opportunity to take voluntary and prompt corrective action before the agency initiates an enforcement action.